/HXBM

HXBM Stock - Helix BioMedix, Inc.

Q: What is the analyst price target for HXBM?

Analyst price target information is not currently available for HXBM.

Q: What is HXBM's market cap?

Market capitalization information is not currently available for HXBM.

Healthcare|Biotechnology|OTC

$2.70+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $2.97

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for HXBM

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.60

52W High$9.00

52W Low$2.70

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$804,229	$997,726	$1.75M	$2.37M	$1.84M
Gross Profit	$797,781	$987,981	$1.74M	$1.93M	$1.73M
Gross Margin	99.2%	99.0%	99.1%	81.3%	94.4%
Operating Income	$-1,064,118	$-984,053	$-1,078,820	$-1,323,243	$-1,230,814
Net Income	$-982,339	$-1,056,057	$-1,192,155	$-1,360,317	$-1,854,653
Net Margin	-122.1%	-105.8%	-67.9%	-57.3%	-101.0%
EPS	$-4.37	$-4.70	$-5.31	$-6.05	$-9.03

Company Overview

Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.

Visit Website